SAS-B monthly prescriber numbers dip below 800 for first time in 2026 by Steve Jones November 2, 2026November 2, 2026 Medicinal cannabis approvals through the Special Access Scheme fell to their second lowest of 2026 in […]
Pastilles overtake flower as most prescribed dosage form for women by Steve Jones September 2, 2026September 2, 2026
SAS-B deep dive: June hits new record for TGA approvals as pastilles surge and oil declines by Steve Jones July 8, 2026July 8, 2026
May SAS-B approvals hit 2026 high as Victoria extends prescribing lead by Adam Sheldon June 3, 2026June 4, 2026
April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026
Former Cannatrek cultivation manager launches living soil operation by Adam Sheldon March 31, 2026April 1, 2026
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
Cann Group delivers ‘modest’ growth as imports continue to frustrate by Steve Jones February 1, 2024February 1, 2024
Flower sales surge past oil as LGP reports 53% rise in Q1 revenue by Steve Jones July 28, 2023April 30, 2024
